| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
2,226
|
8,885
|
1,117
|
1,820
| | Cost of Revenue | 70 | 510 | 510 | 110 | | |
Gross Profit
|
2,156
|
8,375
|
607
|
1,710
| |
|
Operating Expenses |
|
Research Development | 8,721 | 5,423 | 7,551 | 7,957 |
|
Selling General and Administrative | 4,314 | 2,953 | 4,007 | 4,025 |
|
Non Recurring | 116 | 79 | 73 | 162 |
|
Others | 277 | 261 | 291 | 300 |
|
|
|
Total Operating Expenses | 13,428 | 8,716 | 11,922 | 12,444 | | | |
Operating Income or Loss
|
(11,272)
|
(341)
|
(11,315)
|
(10,734)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 14 | 17 | 14 | 14 |
|
Earnings Before Interest And Taxes | (11,258) | (324) | (11,301) | (10,720) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (11,258) | (324) | (11,301) | (10,720) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (11,258) | (324) | (11,301) | (10,720) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(11,258)
|
(324)
|
(11,301)
|
(10,720)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(11,258)
|
(324)
|
(11,301)
|
(10,720)
|
|
0.08(2.05%) 12:56PM EDT - Nasdaq Real Time Price